1. Home
  2. IOSP vs LQDA Comparison

IOSP vs LQDA Comparison

Compare IOSP & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOSP
  • LQDA
  • Stock Information
  • Founded
  • IOSP 1938
  • LQDA 2004
  • Country
  • IOSP United States
  • LQDA United States
  • Employees
  • IOSP N/A
  • LQDA N/A
  • Industry
  • IOSP Major Chemicals
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • IOSP Industrials
  • LQDA Health Care
  • Exchange
  • IOSP Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • IOSP 2.1B
  • LQDA 1.9B
  • IPO Year
  • IOSP 1998
  • LQDA 2018
  • Fundamental
  • Price
  • IOSP $78.29
  • LQDA $24.08
  • Analyst Decision
  • IOSP Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • IOSP 1
  • LQDA 9
  • Target Price
  • IOSP $155.00
  • LQDA $32.67
  • AVG Volume (30 Days)
  • IOSP 247.6K
  • LQDA 2.9M
  • Earning Date
  • IOSP 11-04-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • IOSP 2.15%
  • LQDA N/A
  • EPS Growth
  • IOSP N/A
  • LQDA N/A
  • EPS
  • IOSP 0.77
  • LQDA N/A
  • Revenue
  • IOSP $1,790,700,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • IOSP $0.25
  • LQDA $405.58
  • Revenue Next Year
  • IOSP $7.46
  • LQDA $373.93
  • P/E Ratio
  • IOSP $101.28
  • LQDA N/A
  • Revenue Growth
  • IOSP N/A
  • LQDA 30.20
  • 52 Week Low
  • IOSP $74.10
  • LQDA $9.71
  • 52 Week High
  • IOSP $128.35
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • IOSP 45.69
  • LQDA 52.50
  • Support Level
  • IOSP $77.95
  • LQDA $21.35
  • Resistance Level
  • IOSP $80.11
  • LQDA $23.33
  • Average True Range (ATR)
  • IOSP 1.62
  • LQDA 1.18
  • MACD
  • IOSP 0.17
  • LQDA 0.05
  • Stochastic Oscillator
  • IOSP 53.70
  • LQDA 83.30

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: